9,308
Total Claims
$863K
Drug Cost
1,186
Beneficiaries
$728
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-52%
Cost per patient vs peers
$728 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 8,395 claims · $215K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 213 | $293K |
| Rivaroxaban | 85 | $108K |
| Ticagrelor | 29 | $35K |
| Evolocumab | 26 | $30K |
| Levothyroxine Sodium | 223 | $28K |
| Sitagliptin Phos/Metformin Hcl | 22 | $24K |
| Metoprolol Succinate | 987 | $24K |
| Empagliflozin | 12 | $21K |
| Dapagliflozin Propanediol | 13 | $20K |
| Ranolazine | 77 | $15K |
| Candesartan Cilexetil | 94 | $14K |
| Atorvastatin Calcium | 723 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 19 | $9,740 |
| Rosuvastatin Calcium | 434 | $8,081 |
| Candesartan/Hydrochlorothiazid | 28 | $7,447 |
Prescribing Profile
79
Unique Drugs
$442K
Patient Profile
73
Avg Age
59%
Female
2.08
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data